IDEXX Labs (IDXX) Tops Q2 EPS by 30c; Raises Outlook
Get Alerts IDXX Hot Sheet
Price: $474.02 -0.79%
Revenue Growth %: +7.4%
Financial Fact:
Total cost of revenue: 201.58M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +7.4%
Financial Fact:
Total cost of revenue: 201.58M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $2.34, $0.30 better than the analyst estimate of $2.04. Revenue for the quarter came in at $826 million versus the consensus estimate of $782.99 million.
GUIDANCE:
IDEXX Labs sees FY2021 EPS of $8.20-$8.36, versus the consensus of $8.10. IDEXX Labs sees FY2021 revenue of $3.17-3.205 billion, versus the consensus of $3.14 billion.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Acme United (ACU) Misses Q1 EPS by 20c
- Vail Resorts (MTN) Reports Certain Ski Season Metrics for the Season-to-Date Period Ended April 14
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!